(S)-2-((((S)-3-(4-Chlorophenyl)-4-Phenyl-4,5-Dihydro-1H-Pyrazol-1-Yl)(4-Chlorophenylsulfonamido)Methylene)Amino)-3-Methylbutanamide (S)-2-((((S)-3-(4-氯苯基)-4-苯基-4,5-二氢-1H-吡唑-1-基)(4-氯苯基磺胺基)亚甲基)氨基)-3-甲基丁酰胺
CAS 1392116-14-1 MFCD492116141
化学结构图
SMILES:
别名和识别编码
| Chemical Name Translation | (S)-2-((((S)-3-(4-氯苯基)-4-苯基-4,5-二氢-1H-吡唑-1-基)(4-氯苯基磺胺基)亚甲基)氨基)-3-甲基丁酰胺 |
|---|---|
| Chemical Name | (S)-2-((((S)-3-(4-Chlorophenyl)-4-Phenyl-4,5-Dihydro-1H-Pyrazol-1-Yl)(4-Chlorophenylsulfonamido)Methylene)Amino)-3-Methylbutanamide |
信息真实价格透明
资金保障
专业采购外包团队在线服务
信息真实价格透明
资金保障
专业采购外包团队在线服务
品牌质保精细包装
现货库存
一流品牌服务
相关文献及参考
- [2]. Knani I, et al. Targeting the endocannabinoid/CB1 receptor system for treating obesity in Prader-Willi syndrome. Mol Metab. 2016 Oct 22;5(12):1187-1199.
- [3]. Mukhopadhyay B, et al. Cannabinoid receptor 1 promotes hepatocellular carcinoma initiation and progression through multiple mechanisms. Hepatology. 2015 May;61(5):1615-26.
- [1]. Chorvat RJ. Peripherally restricted CB1 receptor blockers. Bioorg Med Chem Lett. 2013 Sep 1;23(17):4751-60.
- [1]. Chorvat RJ. Peripherally restricted CB1 receptor blockers. Bioorg Med Chem Lett. 2013 Sep 1;23(17):4751-60.
- [2]. Knani I, et al. Targeting the endocannabinoid/CB1 receptor system for treating obesity in Prader-Willi syndrome. Mol Metab. 2016 Oct 22;5(12):1187-1199.
- [3]. Mukhopadhyay B, et al. Cannabinoid receptor 1 promotes hepatocellular carcinoma initiation and progression through multiple mechanisms. Hepatology. 2015 May;61(5):1615-26.
